//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
At today’s lab journal club, we discussed PMC12306285: a trispecific killer engager targeting B7-H3 that boosts NK cell activity against head & neck cancer, even under hypoxia. #Immunotherapy #NKcells #CancerResearch #ImmunoSky jitc.bmj.com/content/13/7...
Background Patients with head and neck squamous cell carcinoma (HNSCC), particularly the human papillomavirus negative (HPV −) subset, have a dismal prognosis. Furthermore, patients with Fanconi anemi...
jitc.bmj.com
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancer
8mo
Djaoud Lab